Colinz Laboratories Limited (BOM:531210)
48.51
+2.31 (5.00%)
At close: May 26, 2026
Colinz Laboratories Revenue
In the fiscal year ending March 31, 2026, Colinz Laboratories had annual revenue of 61.36M INR, down -6.00%. Colinz Laboratories had revenue of 17.48M in the quarter ending March 31, 2026, with 20.43% growth.
Revenue
61.36M
Revenue Growth
-6.00%
P/S Ratio
2.09
Revenue / Employee
944.02K
Employees
65
Market Cap
128.30M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 61.36M | -3.92M | -6.00% |
| Mar 31, 2025 | 65.28M | -5.02M | -7.14% |
| Mar 31, 2024 | 70.30M | -1.25M | -1.75% |
| Mar 31, 2023 | 71.55M | 1.81M | 2.59% |
| Mar 31, 2022 | 69.74M | 8.15M | 13.24% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Beryl Drugs | 176.65M |
| Unjha Formulations | 157.49M |
| Decipher Labs | 148.66M |
| Zenith Healthcare | 113.86M |
| Norris Medicines | 94.44M |
| Desh Rakshak Aushdhalaya | 57.72M |
| Ganga Pharmaceuticals | 28.28M |
| Emmessar Biotech & Nutrition | 24.07M |